(η3-Allyl)[(S)-(+)-(2-pyrrolidinylmethyl)pyrrolidine]palladium(II) trifluoromethanesulfonate
✍ Scribed by Jones, Matthew D. ;Almeida Paz, Filipe A. ;Davies, John E. ;Johnson, Brian F. G.
- Publisher
- International Union of Crystallography
- Year
- 2003
- Tongue
- English
- Weight
- 360 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
1 9.VIII.96) Crystal and solution structures of the enantiomerically pure and the racemic pairs of (q3-allyl) { 2-[2'-(diphenylphosphino)phenyl]-4,5-dihydro-4-phenyloxazole}palladium(II) hexafluorophosphates (1, and rac-1, resp.) and tetraphenylborates (2, and ruc-2, resp.) as well as (q3-ally1){2-[
Novel cationic allylpalladium(II) complexes containing the alkaloid (-)-sparteine (1) as a bidentate ligand have been prepared. Two of them, [q3-(cyclohex-2-enyl)] (sparteine)palladium(II) hexafluorophosphate ([Pd(v3-C6H,)(sparteine)][PF6]; 3b) and (sparteine)[~3-(1,1,3-triphenylallyl)]palladium(II)
## Abstract Crystal and solution structures of the [Pd^II^(η^3^‐allyl)] and of the [Pd^II^(η^3^‐1,3‐diphenylallyl)] complexes, 4 and 5, respectively, with (4__S__)‐4‐benzyl‐2‐[2′‐(diphenylphosphino)phenyl]‐4,5‐dihydrooxazole (3) were determined by X‐ray crystallography and 2D‐NMR spectroscopy. Comp